Search
for
Sort by
Research 61–90 of 747
- Post SARS-CoV-2 vaccination effluvium
- Cutaneous gene therapy
- Key Factors in the Complex and Coordinated Network of Skin Keratinization: Their Significance and Involvement in Common Skin Conditions
- Pathogenesis and clinical features of alopecia in epidermolysis bullosa: A systematic review
- Loose anagen hair syndrome in two patients with epidermolysis bullosa simplex, Dowling-Meara type
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- The Spectrum of Skin Disease Among Indian Children
- Fibroblast heterogeneity: implications for human disease
- Kids are not just little people: Pediatric versus adult dermatology approaches to skin diseases. Part I
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- Dermatomyositis Disease in Dogs
- 570 Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Diseases of Periocular Hair
- Disease severity scoring systems in dermatology
- Scarring Alopecia in Localized Dystrophic Epidermolysis Bullosa: A Case Report and a Scoping Review
- Mesenchymal stem cell-derived exosomes for the treatment of skin and subcutaneous tissue diseases: current evidence from clinical trials
- 568 Evaluating results of an interferon-γ release assay in patients with autoimmune skin disease on hydroxychloroquine
- Skin manifestations of chronic kidney disease
- The spectrum of nephrocutaneous diseases and associations
- 312 CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- Frequency of Childhood Dermatological Diseases: An Analysis of 8551 Cases
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Psychosocial Aspects of Skin Conditions and Diseases
- Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases?
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- New plaque protein identified in brains of people with Alzheimer's disease
- The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond